These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 20553902

  • 1. Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
    Jeong K, Jeong JY, Lee HO, Choi E, Lee H.
    Dev Biol; 2010 Sep 01; 345(1):34-48. PubMed ID: 20553902
    [Abstract] [Full Text] [Related]

  • 2. Genetic approach to evaluate specificity of small molecule drug candidates inhibiting PLK1 using zebrafish.
    Zhong H, Xin S, Zhao Y, Lu J, Li S, Gong J, Yang Z, Lin S.
    Mol Biosyst; 2010 Aug 01; 6(8):1463-8. PubMed ID: 20625580
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X, Choy E, Harmon D, Yang S, Yang C, Mankin H, Hornicek FJ, Duan Z.
    Anticancer Drugs; 2011 Jun 01; 22(5):444-53. PubMed ID: 21399492
    [Abstract] [Full Text] [Related]

  • 4. Heterologous expression of mammalian Plk1 in Drosophila reveals divergence from Polo during late mitosis.
    Pearson J, Godinho SA, Tavares A, Glover DM.
    Exp Cell Res; 2006 Apr 01; 312(6):770-81. PubMed ID: 16412419
    [Abstract] [Full Text] [Related]

  • 5. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo.
    Baran V, Solc P, Kovarikova V, Rehak P, Sutovsky P.
    Mol Reprod Dev; 2013 Jul 01; 80(7):522-34. PubMed ID: 23649868
    [Abstract] [Full Text] [Related]

  • 6. Depletion of Aurora-A in zebrafish causes growth retardation due to mitotic delay and p53-dependent cell death.
    Jeon HY, Lee H.
    FEBS J; 2013 Mar 01; 280(6):1518-30. PubMed ID: 23351126
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
    Neef R, Gruneberg U, Kopajtich R, Li X, Nigg EA, Sillje H, Barr FA.
    Nat Cell Biol; 2007 Apr 01; 9(4):436-44. PubMed ID: 17351640
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 01; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
    Choi M, Kim W, Cheon MG, Lee CW, Kim JE.
    Cancer Lett; 2015 Feb 28; 357(2):591-601. PubMed ID: 25524551
    [Abstract] [Full Text] [Related]

  • 13. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y, Yang Z, Li Q, Song F.
    Oncology; 2008 Feb 28; 74(3-4):198-206. PubMed ID: 18714168
    [Abstract] [Full Text] [Related]

  • 14. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC, Sun SH, Wang FF.
    Cell Signal; 2011 Nov 28; 23(11):1816-23. PubMed ID: 21726628
    [Abstract] [Full Text] [Related]

  • 15. Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands.
    Elling RA, Fucini RV, Romanowski MJ.
    Acta Crystallogr D Biol Crystallogr; 2008 Sep 28; 64(Pt 9):909-18. PubMed ID: 18703838
    [Abstract] [Full Text] [Related]

  • 16. PLK1 inhibitors: setting the mitotic death trap.
    Plyte S, Musacchio A.
    Curr Biol; 2007 Apr 17; 17(8):R280-3. PubMed ID: 17437704
    [Abstract] [Full Text] [Related]

  • 17. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S, Ahmad N.
    FASEB J; 2005 Apr 17; 19(6):611-3. PubMed ID: 15661849
    [Abstract] [Full Text] [Related]

  • 18. Characterization of Polo-like kinase-1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavage.
    Fan HY, Tong C, Teng CB, Lian L, Li SW, Yang ZM, Chen DY, Schatten H, Sun QY.
    Mol Reprod Dev; 2003 Jul 17; 65(3):318-29. PubMed ID: 12784254
    [Abstract] [Full Text] [Related]

  • 19. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.
    Steegmaier M, Hoffmann M, Baum A, Lénárt P, Petronczki M, Krssák M, Gürtler U, Garin-Chesa P, Lieb S, Quant J, Grauert M, Adolf GR, Kraut N, Peters JM, Rettig WJ.
    Curr Biol; 2007 Feb 20; 17(4):316-22. PubMed ID: 17291758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.